Safety of long-term denosumab therapy: results from the open label extension phase of two phase 3 studies in patients with metastatic breast and prostate cancer.

Stopeck, Alison T; Fizazi, Karim; Body, Jean-Jacques; Brown, Janet E; Carducci, Michael; Diel, Ingo; Fujiwara, Yasuhiro; Martín, Miguel; Paterson, Alexander; Tonkin, Katia

doi:10.1007/s00520-015-2904-5

Safety of long-term denosumab therapy: results from the open label extension phase of two phase 3 studies in patients with metastatic breast and prostate cancer.

NobleIDNI6P73W38R52S94

Type:Journal Article

0 views

Support unavailableClaim Your Authorship

Embeddable Badge

[![NobleID](https://www.nobleid.org/api/badge/FFC11CD3.svg?ark=w1%2F20260522%2FFFC11CD3&value=id)](https://nobleid.org/work/w1/20260522/FFC11CD3)

ARK Inflections

Metadata (JSON)Policy

Metadata Formats

Bibliometric Analysis

Impact metrics, research fronts, co-authorship networks →

Authors & Claims

Paper Authors

Claim authorship of this work

Safety of long-term denosumab therapy: results from the open label extension phase of two phase 3 studies in patients with metastatic breast and prostate cancer.

NobleIDNI6P73W38R52S94

Type:Journal Article

0 views

Support unavailableClaim Your Authorship

Embeddable Badge

[![NobleID](https://www.nobleid.org/api/badge/FFC11CD3.svg?ark=w1%2F20260522%2FFFC11CD3&value=id)](https://nobleid.org/work/w1/20260522/FFC11CD3)

ARK Inflections

Metadata (JSON)Policy

Metadata Formats

Bibliometric Analysis

Impact metrics, research fronts, co-authorship networks →

Authors & Claims

Paper Authors

Claim authorship of this work